Why Strengthening Lung Defense Starts from the Gut

A Growing Respiratory Health Concern in Malaysia

Tuberculosis (TB) remains a significant public health challenge in Malaysia, with persistent incidence driven by urban density, comorbidities, and ongoing transmission. At the same time, upper respiratory tract infections (URTI), including common viral infections such as influenza, cold viruses, and COVID-19— are highly prevalent, especially in crowded environments.

While these conditions are often viewed separately, increasing evidence suggests they are biologically interconnected through weakened lung defense and immune dysregulation.

URTI and COVID-19: The First Hit to Lung Defense

URTI and viral respiratory infections are typically considered mild and self-limiting. However, repeated or severe infections, particularly COVID-19 pneumonia, can have deeper consequences:

Damage to the respiratory lining (epithelium)
Disruption of mucosal immunity
Persistent inflammatory responses
Alteration of the respiratory microbiome

This results in a state of impaired lung defense, where the body becomes more vulnerable to secondary or opportunistic infections.

Strong Clinical Signal: COVID-19 and TB Risk

Emerging regional data has highlighted how significant this risk can be.

In a Southeast Asian cohort:

Patients with COVID-19 pneumonia had nearly a 10-fold higher hazard of detectable active pulmonary TB within the first 30 days
The risk remained more than 7-fold higher beyond 30 days

This is a critical insight: Severe respiratory infections are not isolated events—they can significantly increase susceptibility to TB by weakening lung defense.

How URTI Increases the Risk of Tuberculosis

TB infection occurs when Mycobacterium tuberculosis enters the lungs. In healthy individuals, the immune system may contain it.

However, repeated URTI and viral infections do not just cause temporary illness, they initiate a damaging cycle that weakens lung defense and increases TB risk.

The Vicious Cycle of URTI → Lung Damage → TB

1. Barrier Breakdown

Damage to airway lining allows easier entry and colonization of TB bacteria

2. Immune Dysregulation

Overactive inflammation damages tissue
Suppressed immune surveillance reduces bacterial control

3. Compounding Exposure Risk

In Malaysia’s crowded settings:

Higher exposure to airborne infections
Increased transmission of both URTI pathogens and TB

Why These Diseases Co-Exist in Malaysia

The overlap is not coincidental. Shared drivers include:

High population density and crowd exposure
Frequent respiratory infections
Chronic conditions (e.g., diabetes, smoking)
Environmental and lifestyle factors

Together, they form a continuum:

URTI, COVID-19, and TB are interconnected stages of respiratory vulnerability—not isolated diseases.

Why:

Some individuals recover quickly?
Others experience repeated infections or progression to more serious disease?

The Missing Link: The Gut–Lung Axis

Modern science has uncovered a critical connection – the gut–lung axis:

The gut microbiome regulates systemic immunity
Immune signaling from the gut influences lung defense
Dysbiosis (microbial imbalance) weakens immune resilience

Importantly:

Respiratory infections can disrupt gut microbiota, and gut dysbiosis can further impair lung immunity— a two-way relationship.

Why Conventional Approaches Are Not Enough

Current strategies focus on:

Treating infection (antibiotics, antivirals)
Managing symptoms

However, they often do not address the root cause:

Microbiome imbalance
Immune dysregulation
Long-term susceptibility

As a result, recurrence and progression remain common.

A New Approach: Targeting the Root Cause

3rd Generation Probiotics – A Potential Game Changer

Unlike conventional probiotics, 3rd generation probiotics (e.g., SIM01) are developed based on The Chinese University of Hong Kong’s unique metagenomic and AI discovery engine, are designed using:

Disease-specific microbiome insights
Precision strain selection (metagenomics & AI-driven)
Targeted restoration of beneficial bacteria

How SIM01 Fits into This Model

Helps restore specific gut microbiome balance
Supports immune modulation (not suppression)
Reinforces the gut–lung axis
Enhances resilience against repeated respiratory infections

In the context of URTI, COVID-19, and TB:

Instead of only reacting to infection, SIM01 targets the underlying immune foundation.

Putting It All Together

In Malaysia today:

URTI is common and often underestimated
COVID-19 has added a new layer of immune disruption
TB remains endemic

Key Insight

Repeated or severe respiratory infections— including COVID-19— can weaken lung defense and significantly increase vulnerability to TB, with studies showing up to a 10-fold increase in risk in the early phase.

Conclusion: From Infection Control to Immune Resilience

Exposure to infections may be inevitable— especially in crowded environments. The focus must therefore shift from: